Miyachi M - Search Results

1

Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapy.

Kinoshita M, Yamada A, Sawa D, Kamimura S, Miyachi M, Moritake H. Kinoshita M, et al. Among authors: miyachi m. Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26750. Epub 2017 Aug 17. Pediatr Blood Cancer. 2018. PMID: 28834127

2

Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma.

Miyachi M, Tsuchiya K, Yoshida H, Yagyu S, Kikuchi K, Misawa A, Iehara T, Hosoi H. Miyachi M, et al. Biochem Biophys Res Commun. 2010 Sep 10;400(1):89-93. doi: 10.1016/j.bbrc.2010.08.015. Epub 2010 Aug 7. Biochem Biophys Res Commun. 2010. PMID: 20696132

3

FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.

Ouchi K, Miyachi M, Tsuma Y, Tsuchiya K, Iehara T, Konishi E, Yanagisawa A, Hosoi H. Ouchi K, et al. Among authors: miyachi m. Pediatr Blood Cancer. 2015 May;62(5):909-11. doi: 10.1002/pbc.25424. Epub 2015 Feb 14. Pediatr Blood Cancer. 2015. PMID: 25682942

4

Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol.

Miyachi M, Tsuchiya K, Hosono A, Ogawa A, Koh K, Kikuta A, Hara J, Teramukai S, Hosoi H. Miyachi M, et al. Medicine (Baltimore). 2019 Dec;98(52):e18344. doi: 10.1097/MD.0000000000018344. Medicine (Baltimore). 2019. PMID: 31876708 Free PMC article. Clinical Trial.

5

Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma.

Kikuchi K, Tsuchiya K, Otabe O, Gotoh T, Tamura S, Katsumi Y, Yagyu S, Tsubai-Shimizu S, Miyachi M, Iehara T, Hosoi H. Kikuchi K, et al. Among authors: miyachi m. Biochem Biophys Res Commun. 2008 Jan 18;365(3):568-74. doi: 10.1016/j.bbrc.2007.11.017. Epub 2007 Nov 20. Biochem Biophys Res Commun. 2008. PMID: 18022385

6

Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.

Miyachi M, Kakazu N, Yagyu S, Katsumi Y, Tsubai-Shimizu S, Kikuchi K, Tsuchiya K, Iehara T, Hosoi H. Miyachi M, et al. Clin Cancer Res. 2009 Jun 15;15(12):4077-84. doi: 10.1158/1078-0432.CCR-08-2955. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509161

7

MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells.

Otabe O, Kikuchi K, Tsuchiya K, Katsumi Y, Yagyu S, Miyachi M, Iehara T, Hosoi H. Otabe O, et al. Among authors: miyachi m. Oncol Rep. 2017 Jan;37(1):98-104. doi: 10.3892/or.2016.5213. Epub 2016 Nov 2. Oncol Rep. 2017. PMID: 27840956

8

Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.

Sugito N, Taniguchi K, Kuranaga Y, Ohishi M, Soga T, Ito Y, Miyachi M, Kikuchi K, Hosoi H, Akao Y. Sugito N, et al. Among authors: miyachi m. Nucleic Acid Ther. 2017 Dec;27(6):365-377. doi: 10.1089/nat.2017.0673. Epub 2017 Oct 5. Nucleic Acid Ther. 2017. PMID: 28981396

9

Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.

Ouchi K, Miyachi M, Yagyu S, Kikuchi K, Kuwahara Y, Tsuchiya K, Iehara T, Hosoi H. Ouchi K, et al. Among authors: miyachi m. Cancer Cell Int. 2020 May 24;20:192. doi: 10.1186/s12935-020-01282-z. eCollection 2020. Cancer Cell Int. 2020. PMID: 32489328 Free PMC article.

10

Identification of RCC1-LCK as a novel fusion gene in pediatric erythroid sarcoma.

Oya S, Osone S, Yoshida M, Nishimoto S, Taura Y, Yoshida H, Miyachi M, Inaba T, Konishi E, Kato M, Imamura T, Iehara T. Oya S, et al. Among authors: miyachi m. Pediatr Blood Cancer. 2022 Sep;69(9):e29848. doi: 10.1002/pbc.29848. Epub 2022 Jun 30. Pediatr Blood Cancer. 2022. PMID: 35714314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters